The Biotime HCY Rapid Quantitative Test measures homocysteine, a thiol-containing amino acid produced during methionine metabolism. Elevated HCY levels in the bloodstream are associated with endothelial injury, inflammation, and the development of atherosclerotic plaques that can obstruct blood flow to vital organs.

Homocysteine serves as an independent biomarker for atherosclerosis, coronary artery disease, and stroke. It also offers valuable clinical insights into neurological disorders such as Alzheimer’s and Parkinson’s diseases.

The Biotime HCY test is fast, reliable, and easy to perform, requiring only a small plasma sample. Its efficiency and accuracy make it ideal for use in hospitals, emergency vehicles, ICUs, nursing homes, and other healthcare settings.